Employing our established SPR-based liquid biopsy platform with only 10 μL of serum per assay, we found that exosomal TF-Ag-α exhibited exceptional diagnostic performance, achieving 99.2% sensitivity, 100% specificity, and an AUC of 0.999 for distinguishing cancer patients from controls. The gene discussed is TF; the disease is cancer.